Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Blair JD, Bateup HS.

Dev Dyn. 2019 May 9. doi: 10.1002/dvdy.60. [Epub ahead of print] Review.

PMID:
31070828
2.

Genetically engineered human cortical spheroid models of tuberous sclerosis.

Blair JD, Hockemeyer D, Bateup HS.

Nat Med. 2018 Oct;24(10):1568-1578. doi: 10.1038/s41591-018-0139-y. Epub 2018 Aug 20.

3.

Widespread Translational Remodeling during Human Neuronal Differentiation.

Blair JD, Hockemeyer D, Doudna JA, Bateup HS, Floor SN.

Cell Rep. 2017 Nov 14;21(7):2005-2016. doi: 10.1016/j.celrep.2017.10.095.

4.

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.

Blair JD, Bateup HS, Hockemeyer DF.

J Vis Exp. 2016 Feb 2;(108):e53583. doi: 10.3791/53583.

5.

Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancy.

Wilson SL, Blair JD, Hogg K, Langlois S, von Dadelszen P, Robinson WP.

BMC Med Genet. 2015 Dec 11;16:111. doi: 10.1186/s12881-015-0257-z.

6.

To treat and cure them, you must first keep them safe.

Blair JD.

J Healthc Prot Manage. 2015;31(2):80-4. No abstract available.

PMID:
26411054
7.

Genome-wide DNA methylation identifies trophoblast invasion-related genes: Claudin-4 and Fucosyltransferase IV control mobility via altering matrix metalloproteinase activity.

Hu Y, Blair JD, Yuen RK, Robinson WP, von Dadelszen P.

Mol Hum Reprod. 2015 May;21(5):452-65. doi: 10.1093/molehr/gav007. Epub 2015 Feb 19.

8.

Why the dirty bomb is still ticking.

Blair JD.

J Healthc Prot Manage. 2014;30(1):109-15.

PMID:
24707763
9.

Overlapping DNA methylation profile between placentas with trisomy 16 and early-onset preeclampsia.

Blair JD, Langlois S, McFadden DE, Robinson WP.

Placenta. 2014 Mar;35(3):216-22. doi: 10.1016/j.placenta.2014.01.001. Epub 2014 Jan 11.

PMID:
24462402
10.

Eldercare--the coming storm.

Blair JD.

J Healthc Prot Manage. 2013;29(2):101-4.

PMID:
24020327
11.

Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia.

Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP.

Mol Hum Reprod. 2013 Oct;19(10):697-708. doi: 10.1093/molehr/gat044. Epub 2013 Jun 13.

12.

Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta.

Hogg K, Blair JD, McFadden DE, von Dadelszen P, Robinson WP.

PLoS One. 2013 May 7;8(5):e62969. doi: 10.1371/journal.pone.0062969. Print 2013.

13.

The human placenta methylome.

Schroeder DI, Blair JD, Lott P, Yu HO, Hong D, Crary F, Ashwood P, Walker C, Korf I, Robinson WP, LaSalle JM.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6037-42. doi: 10.1073/pnas.1215145110. Epub 2013 Mar 25.

14.

Hypoxia alters the epigenetic profile in cultured human placental trophoblasts.

Yuen RK, Chen B, Blair JD, Robinson WP, Nelson DM.

Epigenetics. 2013 Feb;8(2):192-202. doi: 10.4161/epi.23400. Epub 2013 Jan 11.

15.

Hypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsia.

Hogg K, Blair JD, von Dadelszen P, Robinson WP.

Mol Cell Endocrinol. 2013 Mar 10;367(1-2):64-73. doi: 10.1016/j.mce.2012.12.018. Epub 2012 Dec 26.

PMID:
23274423
16.

Illuminating potential technical artifacts of DNA-methylation array probes.

Blair JD, Price EM.

Am J Hum Genet. 2012 Oct 5;91(4):760-2. doi: 10.1016/j.ajhg.2012.05.028. No abstract available.

17.

An interlaboratory comparison study for the determination of dialkyl phthalate esters in environmental and biological samples.

Ikonomou MG, Kelly BC, Blair JD, Gobas FA.

Environ Toxicol Chem. 2012 Sep;31(9):1948-56. doi: 10.1002/etc.1912. Epub 2012 Jul 13.

PMID:
22707032
18.

Absence of SYCP3 mutations in women with recurrent miscarriage with at least one trisomic miscarriage.

Hanna CW, Blair JD, Stephenson MD, Robinson WP.

Reprod Biomed Online. 2012 Feb;24(2):251-3. doi: 10.1016/j.rbmo.2011.10.013. Epub 2011 Nov 3.

PMID:
22197129
20.

Introduction: The 2011 biennial review of health care management.

Blair JD, Fottler MD.

Adv Health Care Manag. 2011;11:xiii-xviii. No abstract available.

PMID:
22908663
21.

Ultra-trace determination of phthalate ester metabolites in seawater, sediments, and biota from an urbanized marine inlet by LC/ESI-MS/MS.

Blair JD, Ikonomou MG, Kelly BC, Surridge B, Gobas FA.

Environ Sci Technol. 2009 Aug 15;43(16):6262-8.

PMID:
19746723
23.

Perfluoroalkyl contaminants in an Arctic marine food web: trophic magnification and wildlife exposure.

Kelly BC, Ikonomou MG, Blair JD, Surridge B, Hoover D, Grace R, Gobas FA.

Environ Sci Technol. 2009 Jun 1;43(11):4037-43.

PMID:
19569327
24.

Hydroxylated and methoxylated polybrominated diphenyl ethers in a Canadian Arctic marine food web.

Kelly BC, Ikonomou MG, Blair JD, Gobas FA.

Environ Sci Technol. 2008 Oct 1;42(19):7069-77.

PMID:
18939528
25.

To protect in place or evacuate: that is the question.

Blair JD, Scanlon PA, Dluzneski PK.

J Healthc Prot Manage. 2008;24(2):27-32.

PMID:
18800656
26.

Bioaccumulation behaviour of polybrominated diphenyl ethers (PBDEs) in a Canadian Arctic marine food web.

Kelly BC, Ikonomou MG, Blair JD, Gobas FA.

Sci Total Environ. 2008 Aug 15;401(1-3):60-72. doi: 10.1016/j.scitotenv.2008.03.045. Epub 2008 Jun 6.

PMID:
18538377
27.

Ultra-trace analysis of multiple endocrine-disrupting chemicals in municipal and bleached kraft mill effluents using gas chromatography-high-resolution mass spectrometry.

Ikonomou MG, Cai SS, Fernandez MP, Blair JD, Fischer M.

Environ Toxicol Chem. 2008 Feb;27(2):243-51. doi: 10.1897/07-136R.1.

PMID:
18348620
28.
29.

Food web-specific biomagnification of persistent organic pollutants.

Kelly BC, Ikonomou MG, Blair JD, Morin AE, Gobas FA.

Science. 2007 Jul 13;317(5835):236-9. Erratum in: Science. 2007 Oct 5;318(5847):44.

30.

Is the healthcare industry prepared for terrorism?

Blair JD.

J Healthc Prot Manage. 2006;22(1):54-66. No abstract available.

PMID:
17236713
31.
32.

Critical issues for homeland security and health care sector readiness.

Blair JD, Edwards JT.

J Healthc Risk Manag. 2005;25(3):17-21. doi: 10.1002/jhrm.5600250307.

PMID:
20200863
33.

Medical group affiliations: interorganizational relationships and organizational performance.

Rotarius T, Fottler MD, Blair JD.

Health Care Manag (Frederick). 2003 Jan-Mar;22(1):27-33.

PMID:
12688609
34.

An integrated doctoral educational model for developing researchers in health care strategic management.

Payne GT, Nix T, Hoffman J, Blair JD.

J Health Adm Educ. 2001 Summer;19(3):359-74.

PMID:
11764845
35.

The paradox prescription: leading the medical group of the future.

Blair JD, Payne GT.

Health Care Manage Rev. 2000 Winter;25(1):44-58. Review.

PMID:
10710728
36.

Competitive forces in the medical group industry: a stakeholder perspective.

Blair JD, Buesseler JA.

Health Care Manage Rev. 1998 Spring;23(2):7-27.

PMID:
9595307
37.

Strategic choices for medical group practices.

Fottler MD, Blair JD, Rotarius TM, Youngblood MR.

Med Group Manage J. 1996 May-Jun;43(3):32, 34, 36 passim.

PMID:
10157090
38.

Diagnosing the stakeholder bottom line for medical group practices. Key stakeholders' potential to threaten and/or cooperate.

Blair JD, Fottler MD, Whitehead CJ.

Med Group Manage J. 1996 Mar-Apr;43(2):40, 42-8, 50-1. No abstract available.

PMID:
10155945
39.

The problematic fit of diagnosis and strategy for medical group stakeholders--including IDS/Ns.

Blair JD, Rock TT, Rotarius TM, Fottler MD, Bosse GC, Driskill JM.

Health Care Manage Rev. 1996 Winter;21(1):7-28. Review.

PMID:
8647693
40.

Medical practice and physician executives face the uncertain future. Strategic stakeholder management III.

Paolino AR, Greaves JM, Blair JD, Fottler MD, Rotarius TM.

Med Group Manage J. 1995 Sep-Oct;42(5):36, 38-43, 76-8.

PMID:
10161246
41.

Integrated delivery systems/networks in the uncertain future. Strategic stakeholder management, Round One continued.

Rotarius TM, Paolino AR, McMurrough BM, Fottler MD, Blair JD.

Med Group Manage J. 1995 Jul-Aug;42(4):22, 24-6, 28 passim.

PMID:
10144241
42.

Strategic stakeholder management. First round results from 'Facing the Uncertain Future'.

Blair JD, Fottler MD, Lazarus SS, Paolino AR, Rotarius TR.

Med Group Manage J. 1995 May-Jun;42(3):16-8, 20-1.

PMID:
10155930
43.

Urban-rural hospital affiliations: assessing control, fit, and stakeholder issues strategically.

Savage GT, Blair JD, Benson MJ, Hale B.

Health Care Manage Rev. 1992 Winter;17(1):35-49.

PMID:
1548118
44.

Negotiating with interactive scenarios and strategies.

Savage GT, Blair JD, Sorenson R, Buesseler J.

Physician Exec. 1991 May-Jun;17(3):8-15.

PMID:
10160749
45.

Negotiating for more than a slice of the pie.

Blair JD, Savage GT, Whitehead CI, Dymond SB.

Physician Exec. 1991 Mar-Apr;17(2):3-9.

PMID:
10160767
46.

Achieving competitive advantage through strategic human resource management.

Fottler MD, Phillips RL, Blair JD, Duran CA.

Hosp Health Serv Adm. 1990 Fall;35(3):341-63.

PMID:
10106917
47.

Hospital-physician joint ventures: a strategic approach for both dimensions of success.

Blair JD, Slaton CR, Savage GT.

Hosp Health Serv Adm. 1990 Spring;35(1):3-26. Review.

PMID:
10106363
48.

The importance of relationships in hospital negotiation strategies.

Savage GT, Blair JD.

Hosp Health Serv Adm. 1989 Summer;34(2):231-53.

PMID:
10303543
49.

Assessing key stakeholders: who matters to hospitals and why?

Fottler MD, Blair JD, Whitehead CJ, Laus MD, Savage GT.

Hosp Health Serv Adm. 1989 Winter;34(4):525-46.

PMID:
10295896
50.

Stakeholder strategies for the physician executive.

Whitehead CJ, Stanton SY, Buesseler JA, Blair JD.

Physician Exec. 1989 Jul-Aug;15(4):2-6.

PMID:
10316434

Supplemental Content

Loading ...
Support Center